Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Quick Stats
Jan 30, 202656.7
AI Score
HOLD0.85
Volume Ratio
Feb 25, 2026
Next Earnings
10
+ve Days (30d)
15
-ve Days (30d)
SBFM Stock Summary
Last updated Jan 30, 2026
SBFM is currently trading at $1.22, positioned below its 200-day moving average of $1.48, suggesting bearish momentum. The stock has a 52-week range of $1.16 to $3.9.
Technical Analysis: The 50-day moving average stands at $1.34, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.798, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.103, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates SBFM at 56.7/100 with a HOLD recommendation.
SBFM (Sunshine Biopharma Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 39.798 |
| CMF (20) | -0.103 |
| ROC (10) | 0.279 |
| ADX (14) | 13.308 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.035 |
| AROONOSC (14) | -42.857 |
| WILLAMS %R (14) | -86.667 |
| MFI (14) | 36.847 |
SBFM Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
SBFM Price vs Max Options Open Interest
SBFM Max Change In Options Open Interest
SBFM Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SBFM Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SBFM Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
SBFM Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Sunshine Biopharma Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
SBFM Moving Averages Analysis
SBFM (Sunshine Biopharma Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.24 |
| 20 | 1.27 |
| 30 | 1.28 |
| 50 | 1.34 |
| 100 | 1.5 |
| 200 | 1.48 |
SBFM Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 8.2 million |
| Earnings/Share ($) | -15.02 |
| Net Proft Margin (%) | -0.1735 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.83 |
| EPS Estimate Next Year ($) | 0.33 |
| WallStreet Target Price ($) | 7 |
| Most Recent Quarter |